Colin SauderDirector and Clinical Scientist at Karuna Therapeutics
Colin is a director and clinical scientist at Karuna Therapeutics, a biotech committed on bringing novel therapeutics to market in CNS. In his role as clinical scientist, Colin supports Karuna’s ongoing Phase 3 development program in schizophrenia. He is particularly focused on the integration of digital technology in clinical trials to improve outcome assessment and mitigate risk. Before joining Karuna, Colin was a principal investigator and clinical director at a private research site. Prior to joining industry, he held a tenure-track position in the psychiatry department at UT Health San Antonio.